to.adeyemi
Submits third-party assay reports on material purchased directly. Based in Zadar.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
98.65%
n=8
Suppliers covered
7
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042138 | PT-141 (Bremelanotide) | JEEP | JEEP-2601-K8195 | Medutest | 2026-Q2 | 98.92 | 4.36 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043398 | MOTS-c | WXT | WXT-2512-K3109 | Medutest | 2026-Q1 | 97.72 | 2.33 | 102.3 | Buyer-sourced | 0 | FAIL |
| AX-2026-042288 | Epitalon | TFC | TFC-2511-E9934 | Medutest | 2026-Q1 | 99.93 | 6.34 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020535 | Semaglutide | SSA | SSA-2502-U6907 | Janoshik | 2025-Q3 | 97.64 | 5.41 | — | Buyer-sourced | 0 | PASS |
| AX-2024-005121 | Tirzepatide | SGN | SGN-2411-N9012 | PeptideMeter | 2024-Q4 | 99.08 | 2.69 | 96.2 | Buyer-sourced | 0 | PASS |
| AX-2024-004952 | Retatrutide | GGPeps | GGPE-2404-K2899 | Janoshik | 2024-Q3 | 98.43 | 4.62 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004870 | Tirzepatide | ERP | ERP-2406-E9182 | Janoshik | 2024-Q3 | 98.36 | 4.14 | 97.8 | Buyer-sourced | 0 | PASS |
| AX-2024-004651 | Retatrutide | TFC | TFC-2309-H2397 | Janoshik | 2024-Q1 | 98.86 | 3.90 | 99.4 | Buyer-sourced | 0 | PASS |